Project Grant R01MH136354
Award Date
9/25/24
Completion Date
5/31/29
Dollars Obligated
$2.2M
Federal Agency
National Institute of Mental Health
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
This Project Grant award of $3,498,931.00 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports the "Cross Scale Interrogation of NPD Genes (SING) in Mice" research project at Pennsylvania State University, in collaboration with sub-awardees Jackson Laboratory and New York University School of Medicine. The overarching goal is to comprehensively investigate how the loss of 100 neurodevelopmental and psychiatric...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $1,505,818 to Rosalind Franklin University of Medicine & Science to investigate the role of the neurexin protein in social adaptation and amygdala plasticity. The research aims to determine how disruption of the neurexin 1 gene impacts synaptic plasticity within the prefrontal cortex-amygdala circuit, which is critical for flexible social...
This $189,540 federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports research conducted by the University of Pittsburgh to investigate the neural circuitry underlying model-based decision-making. The 5-year grant, awarded on February 1, 2025, aims to determine how distinct cell types in the prelimbic cortex and dorsomedial striatum represent and coordinate model-based control processes that allow...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $422,280 to the University of Colorado-Denver to investigate the intricate nano-scale organization of neurexin proteins and their role in synaptic function. The research project aims to identify novel intracellular proteins that govern the distinct nanoscopic architecture of the neurexin-1 and neurexin-3 proteins at excitatory synapses. Using...
The National Institute of Mental Health (NIMH) awarded a $706,404 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Thomas Jefferson University for the project "PATHOPHYSIOLOGIC ROLES OF PROTEIN-PROTEIN INTERACTIONS AT EXCITATORY SYNAPSES AND THEIR MODIFICATIONS IN SCHIZOPHRENIA." The goal of this 5-year research project is to investigate how defects in protein-protein interactions drive NMDA receptor hypofunction, which is a key aspect of the synaptic...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $206,875 to investigate the impact of GRIN2B/GLUN2B disruption on dopaminergic function and related behavior. The research will use conditional Cre/Lox strategy in mice to assess the effects of diminished GLUN2B signaling on dopaminergic neuron firing, dopamine release, and downstream behavioral changes in impulsivity and habitual learning. The...
This $702,928 Project Grant awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants (CFDA 93.242) program aims to enhance the integration of multi-organ imaging data, psychiatric genetic studies, and functional genomic resources. The key objectives are to: 1) Integrate common and rare genetic variations to understand the co-architecture of psychiatric disorders and multi-organ imaging phenotypes, leveraging data from over 100,000 subjects; 2) Link...
The National Institute of Mental Health (NIMH) awarded a $624,368 Project Grant (CFDA 93.242 - Mental Health Research Grants) to the University of California, San Diego (UCSD) to optimize, pharmacologically test, and mechanistically probe a novel in vivo behavioral and neurophysiological assay for studying risk-taking propensity. The project aims to identify neurophysiological markers of risky versus safe choices during a decision-making task, test the effects of drugs known to impact...
This three-year project grant from the Department of Health and Human Services National Institutes of Health provides $3,555,862 to The Trustees of the University of Pennsylvania under the Trans-NIH Research Support program (CFDA 93.310) to study the interactions between the locus coeruleus-norepinephrine system and the dorsolateral prefrontal cortex in flexible decision-making. Specifically, the researchers will train monkeys on a novel task to quantify how learned expectations and new...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $718,662 to The Trustees of the University of Pennsylvania to conduct research on the cellular and developmental genetic regulation of 3' isoform diversity in the human brain and its contribution to neuropsychiatric disorders such as autism spectrum disorder and schizophrenia. The key objectives of this 5-year research project are to: 1) Generate a...